Figure 3.
HAS1Vb expression by MM B cells correlates with poor survival. Kaplan-Meier survival distributions of MM patients with (-) or without (—) detectable HAS1Vb in the PB at time of diagnosis. HR, 2.6; 95% CI, 1.4 to 4.8; P = .001 using the log-rank rest.